Track Record
Our focus on value creation is why healthcare leaders trust us.
April 2025
Acted as financial advisor to Biofortis in its take-over of Neovix Group, working in close collaboration the CEO and founder of Neovix Group
October 2024
Acted as the sole financial advisor to the Ovizio team and shareholders in the sale of 100% of its shares to Chemometec, a Danish listed company
July 2024
Acted as the sole financial advisor in the reverse merger between Quantum Genomics and ExactCure, a Digital Health company developing AI solutions
May 2024
Acted as the sole financial advisor to Genosciences in €4 million private placement with individual investors
April 2024
Acted as financial advisor to Curio in its 8m€ Series A with RYSE capital
Fev 2024
Advised Mega Dental’s owners on product acquisitions to be internalized, as part of an ongoing Corporate Development-as-a-Service mandate
Jan 2024
Acted as the sole financial advisor to Mega Biopharma in the execution of a strategic partnership with an industrial partner for the co-development and commercialization of MBP products